Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Epigenomic profiling of Non-small-cell Lung Cancer (NSCLC) cells with or without Eed


ABSTRACT: Polycomb repressive complexes (PRC) are frequently implicated in human cancer acting either as oncogenes or tumor suppressors. Here we show that PRC2 is a critical regulator of Kras-driven non-small-cell lung cancer (NSCLC) progression. Modulation of PRC2 by either Ezh2 overexpression or Eed deletion enhances Kras-driven adenomagenesis and inflammation, respectively. Eed-loss-driven inflammation leads to massive macrophage recruitment and marked decline in tissue function. Additional Trp53 inactivation activates a cell autonomous epithelial-to-mesenchymal transition (EMT) program leading to an invasive mucinous adenocarcinoma. A switch between methylated/acetylated chromatin underlies the tumor phenotypic evolution, prominently involving genes controlled by Hippo/Wnt-signaling. Our observations in the mouse models were conserved in human cells. Importantly, PRC2 inactivation results in context-dependent phenotypic alterations, with implications for its therapeutic application. We generated ChIP-seq from primary Kras;p53 (KP) cells in culture with and without Eed (KPE) and from KP primary tumors generated by injection of NSCLC into the tail vein. Mice were sacrificed on the onset of shortness of breath. We generated genome-wide expression profiles (RNA-seq) and Nuclease Accessibility (NA)-seq in primary KP and KPE tumor cells. NA-seq was also performed in A549 cells.

ORGANISM(S): Homo sapiens

SUBMITTER: Gaetano Gargiulo 

PROVIDER: E-GEOD-61190 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer.

Serresi Michela M   Gargiulo Gaetano G   Proost Natalie N   Siteur Bjorn B   Cesaroni Matteo M   Koppens Martijn M   Xie Huafeng H   Sutherland Kate D KD   Hulsman Danielle D   Citterio Elisabetta E   Orkin Stuart S   Berns Anton A   van Lohuizen Maarten M  

Cancer cell 20160101 1


Polycomb repressive complexes (PRC) are frequently implicated in human cancer, acting either as oncogenes or tumor suppressors. Here, we show that PRC2 is a critical regulator of KRAS-driven non-small cell lung cancer progression. Modulation of PRC2 by either Ezh2 overexpression or Eed deletion enhances KRAS-driven adenomagenesis and inflammation, respectively. Eed-loss-driven inflammation leads to massive macrophage recruitment and marked decline in tissue function. Additional Trp53 inactivatio  ...[more]

Similar Datasets

2014-03-06 | E-GEOD-55611 | biostudies-arrayexpress
2012-11-12 | E-GEOD-35981 | biostudies-arrayexpress
2014-05-02 | E-GEOD-52899 | biostudies-arrayexpress
2013-03-05 | E-GEOD-44821 | biostudies-arrayexpress
2014-03-07 | E-GEOD-41487 | biostudies-arrayexpress
2013-03-20 | E-GEOD-36695 | biostudies-arrayexpress
2011-01-21 | E-GEOD-26795 | biostudies-arrayexpress
2013-12-07 | E-GEOD-53076 | biostudies-arrayexpress
2012-02-24 | E-GEOD-36049 | biostudies-arrayexpress
2015-12-07 | E-GEOD-67852 | biostudies-arrayexpress